trending Market Intelligence /marketintelligence/en/news-insights/trending/1UM2_P04P8x2b-uNQ0D1Fw2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Dechra completes acquisition of Brazilian animal health company Venco

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Dechra completes acquisition of Brazilian animal health company Venco

Dechra Pharmaceuticals PLC completed its acquisition of Laboratórios Vencofarma do Brasil Ltda., a Brazilian animal health company, for 185 million reais.

Laboratórios Vencofarma Do Brasil, or Venco, sells vaccines and products for food-producing animals, mainly in Brazil. The company, which also sells companion animal products, is based in Londrina City in Brazil's Paraná state.

Dechra used existing cash and borrowing facilities to finance the deal.

The acquisition provides U.K.-based Dechra with a strategic presence within the Brazilian and South American markets. Dechra said it plans to invest significantly over the next two to three years to develop its business in South America.

Dechra develops and sells animal medicines and related products globally. In January, the company raised £105 million to fund similar deals in the Netherlands.

As of Dec. 17, US$1 was equivalent to 3.89 Brazilian reais.